Back to Search
Start Over
Cardiovascular Risk in Psoriasis: Current State of the Art
- Source :
- Current Vascular Pharmacology. 17:85-91
- Publication Year :
- 2018
- Publisher :
- Bentham Science Publishers Ltd., 2018.
-
Abstract
- Psoriasis (Pso) is a chronic inflammatory immune-mediated skin disease associated with several comorbidities. Despite the growing number of studies providing evidence for the link between Pso and Cardiovascular (CV) disorders, there are still many unsolved questions, dealing with the role of the skin disease as an independent risk factor for CV events, the influence of Pso severity and duration on CV damage, the presence of Psoriatic Arthritis (PsA) as a predictor of increased CV mortality and morbidity and the detection of reliable clinical, laboratory and/or instrumental parameters to stratify CV risk in psoriatic patients. Moreover, it remains to clarify if the early treatment of the dermatosis may lower CV risk. In this paper we will try to provide answers to these queries in the light of the updated data of the literature.
- Subjects :
- medicine.medical_specialty
Psoriasis, Cardiovascular risk, Risk Factors, Coronary Artery Disease
Coronary Artery Disease
Disease
030204 cardiovascular system & hematology
Risk Assessment
Severity of Illness Index
Coronary artery disease
030207 dermatology & venereal diseases
03 medical and health sciences
Psoriatic arthritis
0302 clinical medicine
Risk Factors
Psoriasis
medicine
Humans
Myocardial infarction
Risk factor
Intensive care medicine
Pharmacology
business.industry
Cardiovascular risk
Prognosis
medicine.disease
Dermatology
Cardiovascular Diseases
Metabolic syndrome
Cardiology and Cardiovascular Medicine
business
Subjects
Details
- ISSN :
- 15701611
- Volume :
- 17
- Database :
- OpenAIRE
- Journal :
- Current Vascular Pharmacology
- Accession number :
- edsair.doi.dedup.....d649fecf05f3e389c3dfd38c02220a8d